This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-141-3p | ABL1 | 5.02 | 0 | -1.32 | 0 | MirTarget | -0.18 | 0 | NA | |
2 | hsa-miR-141-3p | ABL2 | 5.02 | 0 | -0.32 | 0.04554 | MirTarget; TargetScan; miRNATAP | -0.13 | 0 | NA | |
3 | hsa-miR-141-3p | ACO1 | 5.02 | 0 | -0.65 | 0.00055 | MirTarget; TargetScan | -0.13 | 0 | NA | |
4 | hsa-miR-141-3p | ADARB1 | 5.02 | 0 | -1.93 | 0 | MirTarget | -0.34 | 0 | NA | |
5 | hsa-miR-141-3p | AFAP1 | 5.02 | 0 | -0.98 | 0.00012 | mirMAP | -0.24 | 0 | NA | |
6 | hsa-miR-141-3p | AKAP2 | 5.02 | 0 | -2.51 | 8.0E-5 | TargetScan | -0.59 | 0 | NA | |
7 | hsa-miR-141-3p | AMOTL1 | 5.02 | 0 | -1.62 | 0 | TargetScan | -0.26 | 0 | NA | |
8 | hsa-miR-141-3p | AMZ1 | 5.02 | 0 | 0.48 | 0.33638 | mirMAP | -0.17 | 0.00019 | NA | |
9 | hsa-miR-141-3p | ANGPTL1 | 5.02 | 0 | -4.51 | 0 | MirTarget | -0.76 | 0 | NA | |
10 | hsa-miR-141-3p | ANK2 | 5.02 | 0 | -4.32 | 0 | TargetScan; miRNATAP | -0.68 | 0 | NA | |
11 | hsa-miR-141-3p | ANKRD44 | 5.02 | 0 | -1.93 | 0 | TargetScan | -0.35 | 0 | NA | |
12 | hsa-miR-141-3p | ANO5 | 5.02 | 0 | -3.19 | 0 | mirMAP | -0.3 | 0 | NA | |
13 | hsa-miR-141-3p | APBB2 | 5.02 | 0 | -0.59 | 0.0014 | MirTarget; TargetScan | -0.17 | 0 | NA | |
14 | hsa-miR-141-3p | APOLD1 | 5.02 | 0 | -2.62 | 0 | TargetScan | -0.24 | 0 | NA | |
15 | hsa-miR-141-3p | ARHGAP24 | 5.02 | 0 | -2.02 | 0 | TargetScan; miRNATAP | -0.38 | 0 | NA | |
16 | hsa-miR-141-3p | ARID5B | 5.02 | 0 | -1.57 | 0 | TargetScan; miRNATAP | -0.16 | 0 | NA | |
17 | hsa-miR-141-3p | ARL10 | 5.02 | 0 | -1.12 | 0.00198 | mirMAP | -0.25 | 0 | NA | |
18 | hsa-miR-141-3p | ARL4A | 5.02 | 0 | -0.62 | 0.01525 | TargetScan | -0.1 | 1.0E-5 | NA | |
19 | hsa-miR-141-3p | ARNT2 | 5.02 | 0 | -1.45 | 0.00019 | mirMAP | -0.13 | 0.00022 | NA | |
20 | hsa-miR-141-3p | ARNTL | 5.02 | 0 | -0.36 | 0.08956 | MirTarget; TargetScan; miRNATAP | -0.1 | 0 | NA | |
21 | hsa-miR-141-3p | ASB1 | 5.02 | 0 | -0.87 | 0 | mirMAP | -0.12 | 0 | NA | |
22 | hsa-miR-141-3p | ASTN1 | 5.02 | 0 | -2.34 | 2.0E-5 | MirTarget; miRNATAP | -0.14 | 0.00582 | NA | |
23 | hsa-miR-141-3p | ASXL3 | 5.02 | 0 | -3.34 | 0 | TargetScan | -0.31 | 0 | NA | |
24 | hsa-miR-141-3p | ATP8A1 | 5.02 | 0 | -1.48 | 8.0E-5 | MirTarget; TargetScan | -0.16 | 1.0E-5 | NA | |
25 | hsa-miR-141-3p | ATXN1 | 5.02 | 0 | -1.51 | 0 | MirTarget; TargetScan; miRNATAP | -0.24 | 0 | NA | |
26 | hsa-miR-141-3p | BACE1 | 5.02 | 0 | -0.72 | 0.00096 | TargetScan; miRNATAP | -0.22 | 0 | NA | |
27 | hsa-miR-141-3p | BACH2 | 5.02 | 0 | -1.52 | 0.00134 | TargetScan | -0.49 | 0 | NA | |
28 | hsa-miR-141-3p | BEND4 | 5.02 | 0 | -1.97 | 7.0E-5 | TargetScan; miRNATAP | -0.29 | 0 | NA | |
29 | hsa-miR-141-3p | BNC2 | 5.02 | 0 | -2.95 | 0 | TargetScan | -0.63 | 0 | NA | |
30 | hsa-miR-141-3p | BVES | 5.02 | 0 | -2.76 | 0 | mirMAP | -0.48 | 0 | NA | |
31 | hsa-miR-141-3p | C11orf21 | 5.02 | 0 | -1.31 | 0.00227 | mirMAP | -0.24 | 0 | NA | |
32 | hsa-miR-141-3p | CACNA2D1 | 5.02 | 0 | -3.32 | 0 | TargetScan | -0.71 | 0 | NA | |
33 | hsa-miR-141-3p | CADM1 | 5.02 | 0 | -1.19 | 0.01251 | MirTarget; TargetScan | -0.16 | 0.00033 | NA | |
34 | hsa-miR-141-3p | CADM2 | 5.02 | 0 | -3.84 | 0 | TargetScan; miRNATAP | -0.3 | 0 | NA | |
35 | hsa-miR-141-3p | CALU | 5.02 | 0 | -0.15 | 0.46318 | TargetScan | -0.2 | 0 | NA | |
36 | hsa-miR-141-3p | CAMK4 | 5.02 | 0 | -1.28 | 0.0022 | mirMAP | -0.29 | 0 | NA | |
37 | hsa-miR-141-3p | CCDC80 | 5.02 | 0 | -3.33 | 0 | MirTarget; TargetScan | -0.69 | 0 | NA | |
38 | hsa-miR-141-3p | CCND2 | 5.02 | 0 | -2.43 | 0 | MirTarget; TargetScan | -0.34 | 0 | NA | |
39 | hsa-miR-141-3p | CCPG1 | 5.02 | 0 | -1 | 0 | MirTarget; miRNATAP | -0.19 | 0 | NA | |
40 | hsa-miR-141-3p | CD274 | 5.02 | 0 | 0.06 | 0.90454 | MirTarget | -0.22 | 0 | NA | |
41 | hsa-miR-141-3p | CD59 | 5.02 | 0 | -0.7 | 0.0013 | mirMAP | -0.1 | 0 | NA | |
42 | hsa-miR-141-3p | CDC25B | 5.02 | 0 | 0.78 | 0.00479 | TargetScan | -0.12 | 0 | NA | |
43 | hsa-miR-141-3p | CDC42EP3 | 5.02 | 0 | -1.35 | 0 | MirTarget; TargetScan | -0.22 | 0 | NA | |
44 | hsa-miR-141-3p | CDK6 | 5.02 | 0 | -0.77 | 0.06479 | TargetScan; miRNATAP | -0.28 | 0 | NA | |
45 | hsa-miR-141-3p | CDON | 5.02 | 0 | -2.61 | 0 | TargetScan; miRNATAP | -0.4 | 0 | NA | |
46 | hsa-miR-141-3p | CDV3 | 5.02 | 0 | -0.42 | 0.0021 | TargetScan; miRNATAP | -0.11 | 0 | NA | |
47 | hsa-miR-141-3p | CELF2 | 5.02 | 0 | -3.05 | 0 | mirMAP; miRNATAP | -0.47 | 0 | NA | |
48 | hsa-miR-141-3p | CEP170 | 5.02 | 0 | -0.11 | 0.58268 | TargetScan | -0.14 | 0 | NA | |
49 | hsa-miR-141-3p | CFL2 | 5.02 | 0 | -2.62 | 0 | TargetScan | -0.42 | 0 | NA | |
50 | hsa-miR-141-3p | CHRDL1 | 5.02 | 0 | -6.15 | 0 | MirTarget; TargetScan | -0.9 | 0 | NA | |
51 | hsa-miR-141-3p | CLIC4 | 5.02 | 0 | -1.72 | 0 | MirTarget | -0.4 | 0 | NA | |
52 | hsa-miR-141-3p | CLIP2 | 5.02 | 0 | -0.8 | 0.00158 | MirTarget; TargetScan | -0.15 | 0 | NA | |
53 | hsa-miR-141-3p | CNTN1 | 5.02 | 0 | -4.98 | 0 | MirTarget; TargetScan; miRNATAP | -0.75 | 0 | NA | |
54 | hsa-miR-141-3p | COL11A1 | 5.02 | 0 | 4.69 | 0 | miRNATAP | -0.23 | 0.00397 | NA | |
55 | hsa-miR-141-3p | COL15A1 | 5.02 | 0 | -0.94 | 0.00988 | MirTarget | -0.34 | 0 | NA | |
56 | hsa-miR-141-3p | COL8A1 | 5.02 | 0 | -0.75 | 0.115 | mirMAP | -0.38 | 0 | NA | |
57 | hsa-miR-141-3p | CORO1C | 5.02 | 0 | -1.12 | 0 | TargetScan | -0.25 | 0 | NA | |
58 | hsa-miR-141-3p | CPEB4 | 5.02 | 0 | -1.56 | 0 | TargetScan | -0.12 | 0 | NA | |
59 | hsa-miR-141-3p | CREB5 | 5.02 | 0 | -2.28 | 0 | mirMAP | -0.41 | 0 | NA | |
60 | hsa-miR-141-3p | CRMP1 | 5.02 | 0 | -1.11 | 0.00158 | MirTarget; TargetScan | -0.23 | 0 | NA | |
61 | hsa-miR-141-3p | CSF3 | 5.02 | 0 | -4.55 | 0 | TargetScan; miRNATAP | -0.54 | 0 | NA | |
62 | hsa-miR-141-3p | CTSB | 5.02 | 0 | 0.1 | 0.67673 | mirMAP | -0.17 | 0 | NA | |
63 | hsa-miR-141-3p | CTTNBP2 | 5.02 | 0 | -2.9 | 1.0E-5 | miRNATAP | -0.24 | 7.0E-5 | NA | |
64 | hsa-miR-141-3p | CXCL12 | 5.02 | 0 | -3.26 | 0 | miRNATAP | -0.58 | 0 | NA | |
65 | hsa-miR-141-3p | CYLD | 5.02 | 0 | -0.89 | 0 | mirMAP | -0.14 | 0 | NA | |
66 | hsa-miR-141-3p | CYP26B1 | 5.02 | 0 | -0.69 | 0.15191 | MirTarget; TargetScan; miRNATAP | -0.38 | 0 | NA | |
67 | hsa-miR-141-3p | DIO2 | 5.02 | 0 | -0.24 | 0.63454 | miRNATAP | -0.29 | 0 | NA | |
68 | hsa-miR-141-3p | DLC1 | 5.02 | 0 | -1.8 | 0 | TargetScan; miRNATAP | -0.21 | 0 | 26278151 | MicroRNA 141 regulates the tumour suppressor DLC1 in colorectal cancer; Luciferase reporter assays and Western blots showed that DLC1 was a direct target of miR-141 in CRC; The expression levels of miR-141 were obviously up-regulated in CRC tissues compared to non-cancerous tissues while DLC1 expression levels were down-regulated in a high proportion of clinical samples 14/18; In addition correlation analyses revealed negative correlation between miR-141 levels and DLC1 expression levels in CRC tissues; In conclusion we demonstrated that miR-141 is up-regulated in CRC and acts as a functional oncogene by targeting DLC1 |
69 | hsa-miR-141-3p | DOCK4 | 5.02 | 0 | -0.48 | 0.07912 | MirTarget; TargetScan | -0.18 | 0 | NA | |
70 | hsa-miR-141-3p | DPYSL3 | 5.02 | 0 | -2.32 | 0 | TargetScan | -0.54 | 0 | NA | |
71 | hsa-miR-141-3p | DSEL | 5.02 | 0 | -1.79 | 0 | TargetScan | -0.29 | 0 | NA | |
72 | hsa-miR-141-3p | DST | 5.02 | 0 | -1.12 | 9.0E-5 | mirMAP | -0.12 | 0 | NA | |
73 | hsa-miR-141-3p | DUSP1 | 5.02 | 0 | -3.47 | 0 | TargetScan | -0.34 | 0 | NA | |
74 | hsa-miR-141-3p | DUSP3 | 5.02 | 0 | -1.04 | 0 | MirTarget; TargetScan; miRNATAP | -0.15 | 0 | NA | |
75 | hsa-miR-141-3p | DYNC1I1 | 5.02 | 0 | -2.05 | 0.0001 | MirTarget | -0.21 | 1.0E-5 | NA | |
76 | hsa-miR-141-3p | DZIP1 | 5.02 | 0 | -1.57 | 2.0E-5 | TargetScan; miRNATAP | -0.29 | 0 | NA | |
77 | hsa-miR-141-3p | EGR2 | 5.02 | 0 | -2.81 | 0 | TargetScan; miRNATAP | -0.47 | 0 | NA | |
78 | hsa-miR-141-3p | ELK3 | 5.02 | 0 | -0.31 | 0.25641 | TargetScan | -0.19 | 0 | NA | |
79 | hsa-miR-141-3p | ELL2 | 5.02 | 0 | -1.08 | 1.0E-5 | TargetScan | -0.13 | 0 | NA | |
80 | hsa-miR-141-3p | ENAH | 5.02 | 0 | -0.68 | 0.00063 | TargetScan | -0.15 | 0 | NA | |
81 | hsa-miR-141-3p | EPB41L3 | 5.02 | 0 | -1.63 | 7.0E-5 | miRNATAP | -0.29 | 0 | NA | |
82 | hsa-miR-141-3p | EPHA7 | 5.02 | 0 | -4.2 | 0 | TargetScan; miRNATAP | -0.33 | 0 | 26261572 | Among those the expression of EPHA7 and PI15 were negatively correlated with that of microRNA-141 and they were also identified as potential targets of this microRNA via microRNA-mRNA interaction; We thus concluded that microRNA-141 EPHA7 and PI15 might jointly participate in the regulation of drug resistance in ovarian cancer and serve as potential targets in targeted therapies |
83 | hsa-miR-141-3p | ERC2 | 5.02 | 0 | -0.08 | 0.86617 | MirTarget; TargetScan | -0.11 | 0.01934 | NA | |
84 | hsa-miR-141-3p | ERG | 5.02 | 0 | -1.35 | 0 | MirTarget; TargetScan | -0.25 | 0 | NA | |
85 | hsa-miR-141-3p | ETS1 | 5.02 | 0 | -0.7 | 0.00228 | mirMAP | -0.14 | 0 | NA | |
86 | hsa-miR-141-3p | FAM133A | 5.02 | 0 | -0.54 | 0.49453 | mirMAP | -0.31 | 1.0E-5 | NA | |
87 | hsa-miR-141-3p | FAM167A | 5.02 | 0 | 0.27 | 0.48779 | mirMAP | -0.19 | 0 | NA | |
88 | hsa-miR-141-3p | FAM168A | 5.02 | 0 | -0.72 | 0.00481 | TargetScan | -0.17 | 0 | NA | |
89 | hsa-miR-141-3p | FAM168B | 5.02 | 0 | -0.95 | 0 | MirTarget; TargetScan | -0.11 | 0 | NA | |
90 | hsa-miR-141-3p | FAM20C | 5.02 | 0 | -1.33 | 0.00181 | MirTarget | -0.46 | 0 | NA | |
91 | hsa-miR-141-3p | FAM26E | 5.02 | 0 | -1.51 | 4.0E-5 | mirMAP | -0.41 | 0 | NA | |
92 | hsa-miR-141-3p | FAM46C | 5.02 | 0 | -1.66 | 0 | TargetScan; miRNATAP | -0.11 | 0.00024 | NA | |
93 | hsa-miR-141-3p | FAT3 | 5.02 | 0 | -2.79 | 0 | MirTarget; miRNATAP | -0.24 | 1.0E-5 | NA | |
94 | hsa-miR-141-3p | FER | 5.02 | 0 | -0.96 | 0.00017 | mirMAP | -0.18 | 0 | NA | |
95 | hsa-miR-141-3p | FGF13 | 5.02 | 0 | -2.8 | 0 | TargetScan | -0.3 | 0 | NA | |
96 | hsa-miR-141-3p | FKBP5 | 5.02 | 0 | -1.54 | 4.0E-5 | TargetScan | -0.39 | 0 | NA | |
97 | hsa-miR-141-3p | FLI1 | 5.02 | 0 | -1.11 | 7.0E-5 | TargetScan | -0.28 | 0 | NA | |
98 | hsa-miR-141-3p | FNIP2 | 5.02 | 0 | -0.76 | 0.01045 | TargetScan | -0.15 | 0 | NA | |
99 | hsa-miR-141-3p | FOXN3 | 5.02 | 0 | -1.44 | 0 | MirTarget; TargetScan; miRNATAP | -0.14 | 0 | NA | |
100 | hsa-miR-141-3p | FOXP2 | 5.02 | 0 | -3.99 | 0 | TargetScan | -0.49 | 0 | NA | |
101 | hsa-miR-141-3p | FRMD6 | 5.02 | 0 | -0.93 | 0.00183 | MirTarget; TargetScan; miRNATAP | -0.12 | 2.0E-5 | NA | |
102 | hsa-miR-141-3p | FSD1L | 5.02 | 0 | -0.15 | 0.71855 | TargetScan | -0.29 | 0 | NA | |
103 | hsa-miR-141-3p | FTO | 5.02 | 0 | -0.52 | 0.0001 | mirMAP | -0.1 | 0 | NA | |
104 | hsa-miR-141-3p | FYCO1 | 5.02 | 0 | -1.62 | 0 | mirMAP | -0.12 | 0 | NA | |
105 | hsa-miR-141-3p | FZD4 | 5.02 | 0 | -0.83 | 0.00068 | TargetScan | -0.11 | 0 | NA | |
106 | hsa-miR-141-3p | GAB2 | 5.02 | 0 | -1.2 | 0 | mirMAP | -0.13 | 0 | NA | |
107 | hsa-miR-141-3p | GATA6 | 5.02 | 0 | -3.38 | 0 | TargetScan; miRNATAP | -0.51 | 0 | NA | |
108 | hsa-miR-141-3p | GCNT2 | 5.02 | 0 | -0.71 | 0.08266 | TargetScan | -0.11 | 0.00337 | NA | |
109 | hsa-miR-141-3p | GDF6 | 5.02 | 0 | -1.14 | 0.02791 | TargetScan | -0.34 | 0 | NA | |
110 | hsa-miR-141-3p | GEM | 5.02 | 0 | -3.69 | 0 | MirTarget | -0.59 | 0 | NA | |
111 | hsa-miR-141-3p | GFRA1 | 5.02 | 0 | -5 | 0 | mirMAP | -0.39 | 0 | NA | |
112 | hsa-miR-141-3p | GFRA2 | 5.02 | 0 | -3.22 | 0 | mirMAP | -0.44 | 0 | NA | |
113 | hsa-miR-141-3p | GJC1 | 5.02 | 0 | -0.97 | 0.00222 | MirTarget; TargetScan; miRNATAP | -0.25 | 0 | NA | |
114 | hsa-miR-141-3p | GLI2 | 5.02 | 0 | -2.29 | 0 | MirTarget | -0.49 | 0 | NA | |
115 | hsa-miR-141-3p | GLRX | 5.02 | 0 | -0.28 | 0.31677 | MirTarget; TargetScan; miRNATAP | -0.13 | 0 | NA | |
116 | hsa-miR-141-3p | GNA12 | 5.02 | 0 | -0.33 | 0.08399 | mirMAP | -0.16 | 0 | NA | |
117 | hsa-miR-141-3p | GNE | 5.02 | 0 | -0.89 | 0.00299 | MirTarget | -0.13 | 0 | NA | |
118 | hsa-miR-141-3p | GNG4 | 5.02 | 0 | 0.22 | 0.74468 | mirMAP | -0.31 | 0 | NA | |
119 | hsa-miR-141-3p | GNG7 | 5.02 | 0 | -3.48 | 0 | MirTarget; TargetScan; miRNATAP | -0.3 | 0 | NA | |
120 | hsa-miR-141-3p | GPC6 | 5.02 | 0 | -2.71 | 0 | TargetScan | -0.64 | 0 | NA | |
121 | hsa-miR-141-3p | GPD1 | 5.02 | 0 | -1.45 | 0.00526 | TargetScan | -0.19 | 6.0E-5 | NA | |
122 | hsa-miR-141-3p | GPM6B | 5.02 | 0 | -2.39 | 0 | TargetScan; miRNATAP | -0.3 | 0 | NA | |
123 | hsa-miR-141-3p | GPR174 | 5.02 | 0 | -0.71 | 0.15454 | TargetScan | -0.28 | 0 | NA | |
124 | hsa-miR-141-3p | GPR63 | 5.02 | 0 | -0.92 | 0.01437 | TargetScan | -0.15 | 1.0E-5 | NA | |
125 | hsa-miR-141-3p | GPRC5B | 5.02 | 0 | -0.92 | 0.00843 | mirMAP | -0.17 | 0 | NA | |
126 | hsa-miR-141-3p | GRAP2 | 5.02 | 0 | -1.99 | 0 | mirMAP | -0.34 | 0 | NA | |
127 | hsa-miR-141-3p | GRIK3 | 5.02 | 0 | -4.42 | 0 | mirMAP | -0.34 | 0 | NA | |
128 | hsa-miR-141-3p | GRIN3A | 5.02 | 0 | -0.24 | 0.40319 | TargetScan; miRNATAP | -0.19 | 0 | NA | |
129 | hsa-miR-141-3p | GSN | 5.02 | 0 | -2.39 | 0 | MirTarget | -0.26 | 0 | NA | |
130 | hsa-miR-141-3p | HAS2 | 5.02 | 0 | -1.45 | 0.00631 | MirTarget | -0.37 | 0 | NA | |
131 | hsa-miR-141-3p | HDAC4 | 5.02 | 0 | -1.8 | 0 | TargetScan; miRNATAP | -0.22 | 0 | NA | |
132 | hsa-miR-141-3p | HECW1 | 5.02 | 0 | 0.08 | 0.87699 | TargetScan | -0.23 | 0 | NA | |
133 | hsa-miR-141-3p | HEYL | 5.02 | 0 | -0.31 | 0.27592 | mirMAP | -0.21 | 0 | NA | |
134 | hsa-miR-141-3p | HGF | 5.02 | 0 | -2.97 | 0 | MirTarget; TargetScan | -0.68 | 0 | NA | |
135 | hsa-miR-141-3p | HIPK3 | 5.02 | 0 | -1.75 | 0 | MirTarget; TargetScan | -0.22 | 0 | NA | |
136 | hsa-miR-141-3p | HIVEP3 | 5.02 | 0 | 0.03 | 0.92033 | mirMAP | -0.17 | 0 | NA | |
137 | hsa-miR-141-3p | HLF | 5.02 | 0 | -5.48 | 0 | TargetScan | -0.59 | 0 | NA | |
138 | hsa-miR-141-3p | HOXA11 | 5.02 | 0 | -0.78 | 0.02922 | TargetScan; miRNATAP | -0.12 | 0.00017 | NA | |
139 | hsa-miR-141-3p | HS3ST3B1 | 5.02 | 0 | -0.64 | 0.18337 | mirMAP | -0.38 | 0 | NA | |
140 | hsa-miR-141-3p | HSPA13 | 5.02 | 0 | -0.29 | 0.10635 | TargetScan | -0.13 | 0 | NA | |
141 | hsa-miR-141-3p | IFFO2 | 5.02 | 0 | -0.91 | 0.00201 | MirTarget; TargetScan | -0.1 | 0.00019 | NA | |
142 | hsa-miR-141-3p | IGDCC4 | 5.02 | 0 | -1.99 | 0 | TargetScan; miRNATAP | -0.35 | 0 | NA | |
143 | hsa-miR-141-3p | IGF2BP2 | 5.02 | 0 | 0.95 | 0.14454 | MirTarget; TargetScan; miRNATAP | -0.31 | 0 | NA | |
144 | hsa-miR-141-3p | IGSF6 | 5.02 | 0 | 0.29 | 0.48351 | TargetScan | -0.26 | 0 | NA | |
145 | hsa-miR-141-3p | IGSF9B | 5.02 | 0 | -3.7 | 0 | TargetScan | -0.38 | 0 | NA | |
146 | hsa-miR-141-3p | IL18R1 | 5.02 | 0 | -0.49 | 0.12464 | MirTarget | -0.13 | 1.0E-5 | NA | |
147 | hsa-miR-141-3p | IL6R | 5.02 | 0 | -1.87 | 0 | MirTarget | -0.24 | 0 | NA | |
148 | hsa-miR-141-3p | IRAK3 | 5.02 | 0 | -1.61 | 0 | mirMAP | -0.24 | 0 | NA | |
149 | hsa-miR-141-3p | IRS2 | 5.02 | 0 | -0.91 | 0.01102 | MirTarget; TargetScan; miRNATAP | -0.16 | 0 | 27186273 | Forced expression of IRS2 reversed the inhibition effect induced by miR-141 overexpression in thyroid cancer cells; Taken together our study provides the first evidence that miR-141 suppressed thyroid cancer cell growth and metastasis through inhibition of IRS2 |
150 | hsa-miR-141-3p | ITGAV | 5.02 | 0 | -0.06 | 0.79571 | MirTarget | -0.13 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL DEVELOPMENT | 77 | 1426 | 6.022e-17 | 2.802e-13 |
2 | REGULATION OF CELL DIFFERENTIATION | 75 | 1492 | 7.616e-15 | 1.191e-11 |
3 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 41 | 513 | 1.024e-14 | 1.191e-11 |
4 | NEUROGENESIS | 72 | 1402 | 1.004e-14 | 1.191e-11 |
5 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 49 | 788 | 3.551e-13 | 2.754e-10 |
6 | CIRCULATORY SYSTEM DEVELOPMENT | 49 | 788 | 3.551e-13 | 2.754e-10 |
7 | CELLULAR COMPONENT MORPHOGENESIS | 52 | 900 | 1.076e-12 | 7.15e-10 |
8 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 49 | 823 | 1.756e-12 | 1.021e-09 |
9 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 74 | 1672 | 6.801e-12 | 3.062e-09 |
10 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 66 | 1395 | 6.552e-12 | 3.062e-09 |
11 | VASCULATURE DEVELOPMENT | 35 | 469 | 7.24e-12 | 3.062e-09 |
12 | TISSUE DEVELOPMENT | 69 | 1518 | 1.233e-11 | 4.782e-09 |
13 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 60 | 1275 | 8.665e-11 | 2.88e-08 |
14 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 56 | 1142 | 8.635e-11 | 2.88e-08 |
15 | BLOOD VESSEL MORPHOGENESIS | 29 | 364 | 1.051e-10 | 3.057e-08 |
16 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 44 | 771 | 1.043e-10 | 3.057e-08 |
17 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 51 | 1021 | 3.521e-10 | 9.637e-08 |
18 | REGULATION OF NEURON DIFFERENTIATION | 35 | 554 | 6.911e-10 | 1.692e-07 |
19 | POSITIVE REGULATION OF CELL DEVELOPMENT | 32 | 472 | 6.819e-10 | 1.692e-07 |
20 | REGULATION OF CELL PROJECTION ORGANIZATION | 35 | 558 | 8.36e-10 | 1.945e-07 |
21 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 25 | 306 | 1.261e-09 | 2.795e-07 |
22 | REGULATION OF CELL DEVELOPMENT | 44 | 836 | 1.323e-09 | 2.798e-07 |
23 | POSITIVE REGULATION OF GENE EXPRESSION | 70 | 1733 | 1.549e-09 | 3.133e-07 |
24 | REGULATION OF CELL MORPHOGENESIS | 34 | 552 | 2.349e-09 | 4.554e-07 |
25 | LOCOMOTION | 52 | 1114 | 2.45e-09 | 4.56e-07 |
26 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 27 | 368 | 2.869e-09 | 5.134e-07 |
27 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 47 | 957 | 3.203e-09 | 5.519e-07 |
28 | NEURON PROJECTION MORPHOGENESIS | 28 | 402 | 4.586e-09 | 7.621e-07 |
29 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 44 | 872 | 4.766e-09 | 7.648e-07 |
30 | NEURON DIFFERENTIATION | 44 | 874 | 5.106e-09 | 7.919e-07 |
31 | NEURON PROJECTION DEVELOPMENT | 33 | 545 | 6.222e-09 | 9.225e-07 |
32 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 28 | 408 | 6.344e-09 | 9.225e-07 |
33 | ANGIOGENESIS | 23 | 293 | 1.25e-08 | 1.762e-06 |
34 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 39 | 750 | 1.708e-08 | 2.337e-06 |
35 | BIOLOGICAL ADHESION | 47 | 1032 | 3.316e-08 | 4.408e-06 |
36 | NEURON DEVELOPMENT | 36 | 687 | 5.178e-08 | 6.511e-06 |
37 | POSITIVE REGULATION OF CELL PROLIFERATION | 40 | 814 | 5.172e-08 | 6.511e-06 |
38 | MUSCLE STRUCTURE DEVELOPMENT | 27 | 432 | 8.254e-08 | 1.011e-05 |
39 | MUSCLE TISSUE DEVELOPMENT | 21 | 275 | 8.69e-08 | 1.037e-05 |
40 | NEURON PROJECTION GUIDANCE | 18 | 205 | 9.139e-08 | 1.063e-05 |
41 | CELL PROJECTION ORGANIZATION | 42 | 902 | 1.043e-07 | 1.184e-05 |
42 | HEART DEVELOPMENT | 28 | 466 | 1.074e-07 | 1.19e-05 |
43 | STEM CELL DIFFERENTIATION | 17 | 190 | 1.59e-07 | 1.72e-05 |
44 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 23 | 337 | 1.629e-07 | 1.723e-05 |
45 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 35 | 689 | 1.695e-07 | 1.753e-05 |
46 | HEAD DEVELOPMENT | 35 | 709 | 3.339e-07 | 3.378e-05 |
47 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 26 | 437 | 3.74e-07 | 3.702e-05 |
48 | REGULATION OF EXTENT OF CELL GROWTH | 12 | 101 | 5.273e-07 | 5.112e-05 |
49 | EMBRYONIC MORPHOGENESIS | 29 | 539 | 6.368e-07 | 6.047e-05 |
50 | CELL PART MORPHOGENESIS | 32 | 633 | 6.52e-07 | 6.068e-05 |
51 | MESENCHYME DEVELOPMENT | 16 | 190 | 8.349e-07 | 7.617e-05 |
52 | CONNECTIVE TISSUE DEVELOPMENT | 16 | 194 | 1.102e-06 | 9.805e-05 |
53 | SENSORY ORGAN DEVELOPMENT | 27 | 493 | 1.117e-06 | 9.805e-05 |
54 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 34 | 724 | 1.524e-06 | 0.0001313 |
55 | REGULATION OF CELL ADHESION | 31 | 629 | 1.67e-06 | 0.0001413 |
56 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 42 | 1004 | 1.763e-06 | 0.0001442 |
57 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 20 | 303 | 1.767e-06 | 0.0001442 |
58 | MESENCHYMAL CELL DIFFERENTIATION | 13 | 134 | 1.859e-06 | 0.0001491 |
59 | POSITIVE REGULATION OF LOCOMOTION | 24 | 420 | 2.146e-06 | 0.0001665 |
60 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 63 | 1805 | 2.127e-06 | 0.0001665 |
61 | REGULATION OF CHONDROCYTE DIFFERENTIATION | 8 | 46 | 2.322e-06 | 0.0001772 |
62 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 17 | 232 | 2.619e-06 | 0.0001965 |
63 | REGULATION OF CARTILAGE DEVELOPMENT | 9 | 63 | 2.996e-06 | 0.0002145 |
64 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 14 | 162 | 2.991e-06 | 0.0002145 |
65 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 62 | 1784 | 2.989e-06 | 0.0002145 |
66 | TAXIS | 25 | 464 | 3.747e-06 | 0.0002641 |
67 | EMBRYO DEVELOPMENT | 38 | 894 | 3.917e-06 | 0.000272 |
68 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 26 | 498 | 4.23e-06 | 0.0002894 |
69 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 8 | 50 | 4.47e-06 | 0.0003014 |
70 | RESPONSE TO WOUNDING | 28 | 563 | 4.544e-06 | 0.000302 |
71 | GROWTH | 23 | 410 | 4.757e-06 | 0.0003117 |
72 | EYE DEVELOPMENT | 20 | 326 | 5.354e-06 | 0.0003413 |
73 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 57 | 1618 | 5.32e-06 | 0.0003413 |
74 | ORGAN MORPHOGENESIS | 36 | 841 | 6.105e-06 | 0.0003839 |
75 | SKELETAL SYSTEM DEVELOPMENT | 24 | 455 | 8.38e-06 | 0.0005199 |
76 | NEURON MIGRATION | 11 | 110 | 8.614e-06 | 0.0005274 |
77 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 19 | 312 | 1.021e-05 | 0.0006169 |
78 | NEGATIVE REGULATION OF CELL COMMUNICATION | 45 | 1192 | 1.075e-05 | 0.000641 |
79 | REGULATION OF DEVELOPMENTAL GROWTH | 18 | 289 | 1.287e-05 | 0.0007429 |
80 | CELL MOTILITY | 35 | 835 | 1.293e-05 | 0.0007429 |
81 | LOCALIZATION OF CELL | 35 | 835 | 1.293e-05 | 0.0007429 |
82 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 49 | 1360 | 1.469e-05 | 0.0008335 |
83 | STEM CELL DIVISION | 6 | 29 | 1.552e-05 | 0.0008594 |
84 | CARDIOCYTE DIFFERENTIATION | 10 | 96 | 1.54e-05 | 0.0008594 |
85 | VASCULOGENESIS | 8 | 59 | 1.589e-05 | 0.0008698 |
86 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 12 | 140 | 1.652e-05 | 0.0008938 |
87 | REGULATION OF EPITHELIAL CELL MIGRATION | 13 | 166 | 1.954e-05 | 0.001044 |
88 | INTRACELLULAR SIGNAL TRANSDUCTION | 54 | 1572 | 1.974e-05 | 0.001044 |
89 | MEMBRANE DEPOLARIZATION | 8 | 61 | 2.041e-05 | 0.001067 |
90 | REGULATION OF AXONOGENESIS | 13 | 168 | 2.219e-05 | 0.001147 |
91 | POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 5 | 19 | 2.338e-05 | 0.001196 |
92 | MULTICELLULAR ORGANISMAL SIGNALING | 11 | 123 | 2.495e-05 | 0.001262 |
93 | DEVELOPMENTAL GROWTH | 19 | 333 | 2.532e-05 | 0.001267 |
94 | MUSCLE ORGAN DEVELOPMENT | 17 | 277 | 2.698e-05 | 0.001335 |
95 | REGULATION OF CELL SIZE | 13 | 172 | 2.845e-05 | 0.001393 |
96 | REGULATION OF CELLULAR COMPONENT SIZE | 19 | 337 | 2.982e-05 | 0.001445 |
97 | EMBRYONIC DIGESTIVE TRACT DEVELOPMENT | 6 | 33 | 3.391e-05 | 0.001627 |
98 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 60 | 1848 | 3.45e-05 | 0.001638 |
99 | REGULATION OF MEMBRANE POTENTIAL | 19 | 343 | 3.791e-05 | 0.001782 |
100 | NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 22 | 437 | 4.035e-05 | 0.001878 |
101 | REGULATION OF CELL PROLIFERATION | 51 | 1496 | 4.201e-05 | 0.001935 |
102 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 27 | 609 | 5.083e-05 | 0.002319 |
103 | TUBE MORPHOGENESIS | 18 | 323 | 5.596e-05 | 0.002528 |
104 | HEART MORPHOGENESIS | 14 | 212 | 6.274e-05 | 0.002807 |
105 | REGULATION OF STEM CELL DIFFERENTIATION | 10 | 113 | 6.358e-05 | 0.002817 |
106 | FOREBRAIN DEVELOPMENT | 19 | 357 | 6.486e-05 | 0.002847 |
107 | HINDBRAIN DEVELOPMENT | 11 | 137 | 6.755e-05 | 0.00291 |
108 | SKELETAL MUSCLE ORGAN DEVELOPMENT | 11 | 137 | 6.755e-05 | 0.00291 |
109 | TUBE DEVELOPMENT | 25 | 552 | 6.883e-05 | 0.002938 |
110 | PROTEIN PHOSPHORYLATION | 36 | 944 | 7.029e-05 | 0.002959 |
111 | NEGATIVE REGULATION OF PHOSPHORYLATION | 21 | 422 | 7.106e-05 | 0.002959 |
112 | REGULATION OF ORGAN MORPHOGENESIS | 15 | 242 | 7.122e-05 | 0.002959 |
113 | ACTIN FILAMENT BASED MOVEMENT | 9 | 93 | 7.353e-05 | 0.003028 |
114 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 32 | 801 | 7.656e-05 | 0.003125 |
115 | CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 5 | 24 | 7.899e-05 | 0.003196 |
116 | SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE | 4 | 13 | 8.255e-05 | 0.003311 |
117 | CARDIAC MUSCLE CELL DIFFERENTIATION | 8 | 74 | 8.415e-05 | 0.003347 |
118 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 6 | 39 | 9.067e-05 | 0.003575 |
119 | EPITHELIAL TO MESENCHYMAL TRANSITION | 7 | 56 | 9.245e-05 | 0.003585 |
120 | OUTFLOW TRACT MORPHOGENESIS | 7 | 56 | 9.245e-05 | 0.003585 |
121 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 38 | 1036 | 9.928e-05 | 0.003728 |
122 | MEMBRANE ASSEMBLY | 5 | 25 | 9.72e-05 | 0.003728 |
123 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 38 | 1036 | 9.928e-05 | 0.003728 |
124 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 30 | 740 | 9.934e-05 | 0.003728 |
125 | VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 4 | 14 | 0.0001138 | 0.004203 |
126 | MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 4 | 14 | 0.0001138 | 0.004203 |
127 | CELL CELL ADHESION | 26 | 608 | 0.0001253 | 0.004591 |
128 | CARTILAGE DEVELOPMENT | 11 | 147 | 0.0001273 | 0.004628 |
129 | METENCEPHALON DEVELOPMENT | 9 | 100 | 0.0001293 | 0.004665 |
130 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 24 | 541 | 0.0001315 | 0.00467 |
131 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 24 | 541 | 0.0001315 | 0.00467 |
132 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 9 | 103 | 0.0001623 | 0.00572 |
133 | ACTIN FILAMENT BASED PROCESS | 21 | 450 | 0.0001737 | 0.006075 |
134 | REGULATION OF FAT CELL DIFFERENTIATION | 9 | 106 | 0.0002019 | 0.006878 |
135 | CARDIAC MUSCLE CELL CONTRACTION | 5 | 29 | 0.000204 | 0.006878 |
136 | POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 5 | 29 | 0.000204 | 0.006878 |
137 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 4 | 16 | 0.0002008 | 0.006878 |
138 | MUSCLE CELL DIFFERENTIATION | 14 | 237 | 0.0002038 | 0.006878 |
139 | BONE DEVELOPMENT | 11 | 156 | 0.0002149 | 0.007195 |
140 | AMINOGLYCAN BIOSYNTHETIC PROCESS | 9 | 107 | 0.0002168 | 0.007206 |
141 | CARDIAC SEPTUM DEVELOPMENT | 8 | 85 | 0.0002239 | 0.007389 |
142 | MEMBRANE BIOGENESIS | 5 | 30 | 0.000241 | 0.007897 |
143 | EPITHELIAL CELL DIFFERENTIATION | 22 | 495 | 0.0002429 | 0.007902 |
144 | CELL JUNCTION ORGANIZATION | 12 | 185 | 0.000245 | 0.007916 |
145 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 36 | 1008 | 0.0002542 | 0.008158 |
146 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 52 | 1656 | 0.0002774 | 0.008723 |
147 | RESPONSE TO ENDOGENOUS STIMULUS | 47 | 1450 | 0.0002769 | 0.008723 |
148 | EXTRACELLULAR STRUCTURE ORGANIZATION | 16 | 304 | 0.0002743 | 0.008723 |
149 | DIGESTIVE TRACT MORPHOGENESIS | 6 | 48 | 0.000295 | 0.009213 |
150 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 21 | 472 | 0.00033 | 0.009996 |
151 | GLOMERULUS DEVELOPMENT | 6 | 49 | 0.0003308 | 0.009996 |
152 | REGULATION OF ACTIN CYTOSKELETON REORGANIZATION | 5 | 32 | 0.00033 | 0.009996 |
153 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 35 | 983 | 0.000328 | 0.009996 |
154 | ADIPOSE TISSUE DEVELOPMENT | 5 | 32 | 0.00033 | 0.009996 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 36 | 629 | 5.434e-09 | 5.048e-06 |
2 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 51 | 1199 | 7.263e-08 | 3.374e-05 |
3 | CYTOSKELETAL PROTEIN BINDING | 37 | 819 | 1.295e-06 | 0.0003007 |
4 | REGULATORY REGION NUCLEIC ACID BINDING | 37 | 818 | 1.258e-06 | 0.0003007 |
5 | SEQUENCE SPECIFIC DNA BINDING | 42 | 1037 | 3.97e-06 | 0.0007377 |
6 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 20 | 328 | 5.865e-06 | 0.0009081 |
7 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 18 | 315 | 4.043e-05 | 0.004695 |
8 | SEMAPHORIN RECEPTOR ACTIVITY | 4 | 11 | 3.928e-05 | 0.004695 |
9 | ACTIN BINDING | 20 | 393 | 7.767e-05 | 0.008018 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 60 | 1151 | 1.302e-12 | 7.603e-10 |
2 | CELL PROJECTION | 74 | 1786 | 1.491e-10 | 4.352e-08 |
3 | SYNAPSE | 42 | 754 | 5.996e-10 | 1.167e-07 |
4 | NEURON PART | 54 | 1265 | 2.527e-08 | 3.69e-06 |
5 | NEURON PROJECTION | 42 | 942 | 3.36e-07 | 3.925e-05 |
6 | CELL LEADING EDGE | 22 | 350 | 1.216e-06 | 0.0001183 |
7 | CYTOSKELETON | 65 | 1967 | 8.748e-06 | 0.0007298 |
8 | SITE OF POLARIZED GROWTH | 12 | 149 | 3.082e-05 | 0.00191 |
9 | CELL SUBSTRATE JUNCTION | 21 | 398 | 3.06e-05 | 0.00191 |
10 | CELL PROJECTION PART | 37 | 946 | 3.271e-05 | 0.00191 |
11 | SEMAPHORIN RECEPTOR COMPLEX | 4 | 11 | 3.928e-05 | 0.002085 |
12 | ACTIN CYTOSKELETON | 22 | 444 | 5.11e-05 | 0.002273 |
13 | CELL CELL JUNCTION | 20 | 383 | 5.449e-05 | 0.002273 |
14 | MICROTUBULE END | 5 | 22 | 5.051e-05 | 0.002273 |
15 | ANCHORING JUNCTION | 23 | 489 | 7.644e-05 | 0.002976 |
16 | LAMELLIPODIUM | 12 | 172 | 0.000124 | 0.004526 |
17 | SIDE OF MEMBRANE | 20 | 428 | 0.0002425 | 0.008331 |
18 | MICROTUBULE PLUS END | 4 | 17 | 0.0002586 | 0.00839 |
19 | MEMBRANE REGION | 39 | 1134 | 0.0002999 | 0.009217 |
20 | SYNAPSE PART | 25 | 610 | 0.0003205 | 0.00936 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04514_Cell_adhesion_molecules_.CAMs. | 12 | 136 | 1.231e-05 | 0.002216 | |
2 | hsa04390_Hippo_signaling_pathway | 10 | 154 | 0.0007874 | 0.07087 | |
3 | hsa04014_Ras_signaling_pathway | 12 | 236 | 0.002073 | 0.1244 | |
4 | hsa04722_Neurotrophin_signaling_pathway | 8 | 127 | 0.003121 | 0.1404 | |
5 | hsa04010_MAPK_signaling_pathway | 12 | 268 | 0.005749 | 0.207 | |
6 | hsa04310_Wnt_signaling_pathway | 8 | 151 | 0.008732 | 0.262 | |
7 | hsa04360_Axon_guidance | 7 | 130 | 0.01268 | 0.3261 | |
8 | hsa04151_PI3K_AKT_signaling_pathway | 13 | 351 | 0.01834 | 0.4126 | |
9 | hsa04630_Jak.STAT_signaling_pathway | 7 | 155 | 0.02995 | 0.599 | |
10 | hsa04380_Osteoclast_differentiation | 6 | 128 | 0.03677 | 0.6619 | |
11 | hsa04962_Vasopressin.regulated_water_reabsorption | 3 | 44 | 0.05183 | 0.8162 | |
12 | hsa04810_Regulation_of_actin_cytoskeleton | 8 | 214 | 0.05441 | 0.8162 | |
13 | hsa04710_Circadian_rhythm_._mammal | 2 | 23 | 0.07106 | 0.8591 | |
14 | hsa00760_Nicotinate_and_nicotinamide_metabolism | 2 | 24 | 0.07657 | 0.8591 | |
15 | hsa04350_TGF.beta_signaling_pathway | 4 | 85 | 0.08039 | 0.8591 | |
16 | hsa04512_ECM.receptor_interaction | 4 | 85 | 0.08039 | 0.8591 | |
17 | hsa04012_ErbB_signaling_pathway | 4 | 87 | 0.08586 | 0.8591 | |
18 | hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series | 2 | 26 | 0.08797 | 0.8591 | |
19 | hsa04510_Focal_adhesion | 7 | 200 | 0.09068 | 0.8591 | |
20 | hsa04110_Cell_cycle | 5 | 128 | 0.0998 | 0.8982 | |
21 | hsa04912_GnRH_signaling_pathway | 4 | 101 | 0.1289 | 1 | |
22 | hsa04916_Melanogenesis | 4 | 101 | 0.1289 | 1 | |
23 | hsa04720_Long.term_potentiation | 3 | 70 | 0.1505 | 1 | |
24 | hsa04130_SNARE_interactions_in_vesicular_transport | 2 | 36 | 0.151 | 1 | |
25 | hsa04971_Gastric_acid_secretion | 3 | 74 | 0.169 | 1 | |
26 | hsa04640_Hematopoietic_cell_lineage | 3 | 88 | 0.2379 | 1 | |
27 | hsa04540_Gap_junction | 3 | 90 | 0.2481 | 1 | |
28 | hsa04530_Tight_junction | 4 | 133 | 0.2512 | 1 | |
29 | hsa04020_Calcium_signaling_pathway | 5 | 177 | 0.2522 | 1 | |
30 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 3 | 95 | 0.2739 | 1 | |
31 | hsa04340_Hedgehog_signaling_pathway | 2 | 56 | 0.2911 | 1 | |
32 | hsa04062_Chemokine_signaling_pathway | 5 | 189 | 0.2962 | 1 | |
33 | hsa04660_T_cell_receptor_signaling_pathway | 3 | 108 | 0.342 | 1 | |
34 | hsa04920_Adipocytokine_signaling_pathway | 2 | 68 | 0.3752 | 1 | |
35 | hsa04115_p53_signaling_pathway | 2 | 69 | 0.382 | 1 | |
36 | hsa04270_Vascular_smooth_muscle_contraction | 3 | 116 | 0.3837 | 1 | |
37 | hsa04730_Long.term_depression | 2 | 70 | 0.3888 | 1 | |
38 | hsa04520_Adherens_junction | 2 | 73 | 0.409 | 1 | |
39 | hsa04664_Fc_epsilon_RI_signaling_pathway | 2 | 79 | 0.4484 | 1 | |
40 | hsa04974_Protein_digestion_and_absorption | 2 | 81 | 0.4613 | 1 | |
41 | hsa04910_Insulin_signaling_pathway | 3 | 138 | 0.4943 | 1 | |
42 | hsa04914_Progesterone.mediated_oocyte_maturation | 2 | 87 | 0.4986 | 1 | |
43 | hsa04210_Apoptosis | 2 | 89 | 0.5107 | 1 | |
44 | hsa04970_Salivary_secretion | 2 | 89 | 0.5107 | 1 | |
45 | hsa04142_Lysosome | 2 | 121 | 0.6769 | 1 | |
46 | hsa04145_Phagosome | 2 | 156 | 0.803 | 1 | |
47 | hsa04144_Endocytosis | 2 | 203 | 0.9032 | 1 | |
48 | hsa04740_Olfactory_transduction | 2 | 388 | 0.9955 | 1 |